Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
PMCID: PMC5551541
A dedicated Phase 3 trial evaluating retatrutide specifically for metabolic dysfunction-associated steatotic liver disease is currently underway
Otherwise, skip it and continue with your next dose as scheduled
Side effects can vary depending on the individual and the specific medication
Thyroid C-cell tumors An increased risk of this specific type of cancer has only been seen in rodent studies, not in humans
US$ 21.52
US$ 29.28
US$ 21.36
US$ 23.52
US$ 26.09
US$ 21.00
US$ 25.45
US$ 27.84
US$ 20.77
US$ 20.90
US$ 22.89
US$ 20.89
